COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 20 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,256,571 | -15.9% | 463,899 | 0.0% | 0.62% | -18.4% |
| Q4 2022 | $3,873,557 | +41.2% | 463,899 | +14.9% | 0.76% | +28.0% |
| Q3 2022 | $2,744,000 | -50.5% | 403,573 | -41.8% | 0.59% | +4.0% |
| Q2 2022 | $5,544,000 | +11.2% | 693,066 | +55.9% | 0.57% | -34.9% |
| Q1 2022 | $4,987,000 | -50.5% | 444,444 | -27.8% | 0.88% | -46.1% |
| Q4 2021 | $10,071,000 | +4.4% | 615,554 | +7.8% | 1.62% | -12.4% |
| Q3 2021 | $9,648,000 | -14.2% | 570,901 | +7.7% | 1.85% | -14.3% |
| Q2 2021 | $11,243,000 | – | 530,104 | – | 2.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $11,942,000 | 13.95% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 530,104 | $11,243,000 | 2.16% |
| FRIESS ASSOCIATES LLC | 235,092 | $4,986,000 | 1.88% |
| Weil Company, Inc. | 30,468 | $646,000 | 0.33% |
| VILLERE ST DENIS J & CO LLC | 247,250 | $5,244,000 | 0.28% |
| ACT CAPITAL MANAGEMENT, LLC | 7,500 | $160,000 | 0.08% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 64,634 | $1,371,000 | 0.07% |
| FNY Investment Advisers, LLC | 4,000 | $84,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 597 | $13,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,800 | $441,000 | 0.00% |